Modular program-based one-time assessment of rhabdomyolysis events following new use of statins, including atorvastatin, fluvastatin, lovastatin, pitavastatin, pravastatin, rosuvastatin, and simvastatin. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2006 to May 31, 2013. Modular programs are adaptable standardized programs. Results were generated using Modular Program 3; click here for more information. Queries were distributed in June 2014. This report includes data from 12 Data Partners.
If you are using a web page screen reader and are unable to access this document, please contact the Mini-Sentinel Operations Center for assistance by clicking on the Submit Comments link above or sending an email requesting assistance to email@example.com.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.